BACKGROUND: The traditional outcome measured following treatment of Dupuytren's Disease (DD) has been digital range of motion  specifically the gain in digital extension The outcomes research movement in the last three decades however has been advocating the measurement of outcomes from the patient's perspective using Health-Related Quality of Life questionnaires (HRQOL)